NUCLEOTIDE SEQUENCES WHICH CODE FOR THE PPSA GENE

Abstract: The invention relates to an isolated polynucleotide comprising a polynucleotide sequence chosen from the group consisting of a) polynucleotide which is identical to the extent of at least 70% to a polynucleotide which codes for a polypeptide which comprises the amino acid sequence of SEQ ID No. 2, b) polynucleotide which codes for a polypeptide which comprises an amino acid sequence which is identical to the extent of at least 70% to the amino acid sequence of SEQ ID No. 2, c) polynucleotide which is complementary to the polynucleotides of a) or b), and d) polynucleotide comprising at least 15 successive nucleotides of the polynucleotide sequence of a), b) or c), and a process for the fermentative preparation of L-amino acids using coryneform bacteria in which at least the ppsA gene is present in enhanced form, and the use of polynucleotides which comprise the sequences according to the invention as hybridization probes.

Description: Nucleotide sequences which code for the ppsA gene Field of the Invention The invention provides nucleotide sequences from coryneform bacteria which code for the ppsA gene and a process for the fermentative preparation of amino acids using bacteria in which the ppsA gene is enhanced. Prior Art L-Amino acids, in particular L-lysine, are used in human medicine and in the pharmaceuticals industry, in the foodstuffs industry and very particularly in animal nutrition. It is known that amino acids are prepared by fermentation from strains of coryneform bacteria, in particular Corynebacterium glutamicum. Because of their great importance, work is constantly being undertaken to improve the preparation processes. Improvements to the process can relate to fermentation measures, such as, for example, stirring and supply of oxygen, or the composition of the nutrient media, such as, for example, the sugar concentration during the fermentation, or the working up to the product form by, for example, ion exchange chromatography, or the intrinsic output properties of the microorganism itself. Methods of mutagenesis, selection and mutant selection are used to improve the output properties of these microorganisms. Strains which are resistant to anti etabolites or are auxotrophic for metabolites of regulatory importance and produce amino acids are obtained in this manner. Methods of the recombinant DNA technique have also been employed for some years for improving the strain of Corynebacterium strains which produce L-amino acid, by amplifying individual amino acid biosynthesis genes and investigating the effect on the amino acid production. Object of the Invention The inventors had the object of providing new measures for improved fermentative preparation of amino acids. Summary of the Invention Where L-amino acids or amino acids are mentioned in the following, this means one or more amino acids, including their salts, chosen from the group consisting of L- asparagine, L-threonine, L-serine, L-glutamate, L-glycine, L-alanine, L-cysteine, L-valine, L-methionine, L- isoleucine, L-leucine, L-tyrosine, L-phenylalanine, L- histidine, L-lysine, L-tryptophan and L-arginine. L-Lysine is particularly preferred. When L-lysine or lysine are mentioned in the following, not only the bases but also the salts, such as e.g. lysine monohydrochloride or lysine sulfate, are meant by this. The invention provides an isolated polynucleotide from coryneform bacteria, comprising a polynucleotide sequence which codes for the ppsA gene, chosen from the group consisting of a) polynucleotide which is identical to the extent of at least 70% to a polynucleotide which codes for a polypeptide which comprises the amino acid sequence of SEQ ID No. 2, b) polynucleotide which codes for a polypeptide which comprises an amino acid sequence which is identical to the extent of at least 70% to the amino acid sequence of SEQ ID No. 2, c) polynucleotide which is complementary to the polynucleotides of a) or b) , and d) polynucleotide comprising at least 15 successive nucleotides of the polynucleotide sequence of a) , b) or c), the polypeptide preferably having the activity of phosphoenol pyruvate synthase. The invention also provides the abovementioned polynucleotide, this preferably being a DNA which is capable of replication, comprising: (i) the nucleotide sequence shown in SEQ ID No. 1, or (ii) at least one sequence which corresponds to sequence (i) within the range of the degeneration of the genetic code, or (iii) at least one sequence which hybridizes with the sequence complementary to sequence (i) or (ii) , and optionally (iv) sense mutations of neutral function in (i) . The invention also provides a polynucleotide, in particular DNA, which is capable of replication and comprises the nucleotide sequence as shown in SEQ ID No. 1; a polynucleotide which codes for a polypeptide which comprises the amino acid sequence as shown in SEQ ID No. 2; a vector containing the polynucleotide according to the invention, in particular a shuttle vector or plasmid vector, and coryneform bacteria which contain the vector or in which the ppsA gene is enhanced. CO > M o n o n O Cn t n o O H ω o o 3 d Ω !-• φ o rt H- α Φ O Cu l-i φ o TJ rt H- O 3 Cu I- 1 ■ CU H n O CO d H- rt- Cu tr φ • "Isolated" means separated out of its natural environment. "Polynucleotide" in general relates to polyribonucleotides and polydeoxyribonucleotides, it being possible for these to be non-modified RNA or DNA or modified RNA or DNA. The polynucleotides according to the invention include a polynucleotide according to SEQ ID No. 1 or a fragment prepared therefrom and also those which are at least 70% to 80%, preferably at least 81% to 85%, particularly preferably at least 86% to 90%, and very particularly preferably at least 91%, 93%, 95%, 97% or 99% identical to the polynucleotide according to SEQ ID No. 1 or a fragment prepared therefrom. "Polypeptides" are understood as meaning peptides or proteins which comprise two or more amino acids bonded via peptide bonds. The polypeptides according to the invention include a polypeptide according to SEQ ID No. 2, in particular those with the biological activity of phosphoenol pyruvate synthase, and also those which are at least 70% to 80%, preferably at least 81% to 85%, particularly preferably at least 86% to 90%, and very particularly preferably at least 91%, 93%, 95%, 97% or 99% identical to the polypeptide according to SEQ ID No. 2 and have the activity mentioned. The invention furthermore relates to a process for the fermentative preparation of amino acids chosen from the group consisting of L-asparagine, L-threonine, L-serine, L- glutamate, L-glycine, L-alanine, L-cysteine, L-valine, L- methionine, L-isoleucine, L-leucine, L-tyrosine, L- phenylalanine, L-histidine, L-lysine, L-tryptophan and L- arginine using coryneform bacteria which in particular already produce amino acids and in which the nucleotide sequences which code for the ppsA gene are enhanced, in particular over-expressed. O IV) f μ> o c o Cn o Cn ιΩ TJ O TJ ιQ 3 O Ω iQ ι-h J H3 3 u > H» μ- CU ω Cu d Ω Ω Φ μ- m M Cu d H h- 1 Φ O o h- 1 hi hj tr μ- Ω o cn 3 Ω CO O O 3 3 tr d H μ- O d 3 hj hj ><: d O φ Ω rt o o rt ^ μ- TJ hi N Ω Φ rt rt liα rt rt << *< Ω Ω a hj μ- o o\o ιQ μ- Φ μ- 3 μ- hi ^ hi Cu μ- eu U μ- 3 3 Φ rt d 3 o <! o\o ^» Φ 0 3 ιΩ ιΩ Φ Φ 3 Φ rt 3 Ω tr Ω 3 O Φ φ hj O Ω μ- o μ- . 3 μ- tr ^ ω CQ φ Cu Φ μ- d M φ μ- 3 σ H O CO Φ o H rt K) Φ rt Cu Cu J CO CO hj Ω M Φ Ω Φ Cu o Φ H ιΩ ^ tr O hj ■ 3 Cu o 0 φ 3 d Cu t- 1 d α Ω H t-< 0 CU cu O Cu Ω 0 ιΩ Hi 3 μ- 3_ H CO 1 3 rt 3 Cu 1 0 3 o CO o\o I- 1 o φ rt Φ 3 μ- 2 da tD rjd O O O Ω O rt Cu * * μ- Φ 3 3 Cu h μ- l-S Φ •« hi 3 μ- 3 rt μ- 3 Φ hj j hj o O O O O O hi 3 3 H σ Cu 3 >Ω o 0- μ- Φ < Φ 3' 3 cu 3 Φ Φ Φ hi hj H H H Hi CU μ- s: μ- Cu μ- Cu 3 Ω CO 3 Ω 3 μ- Φ IΩ rt 3' <l <! < * ^ ^ ^ ^ Cu μ- 3 3 * TJ d Ω Φ rt 3 3 O 0 O Ω 0 rt rt s: 3 3- Cu μ- μ- μ- 3 3 3 3 3 hi rt 3 0 μ- CU 3 rt rt O o μ- 3 3 O H 3 ■ : tr ιΩ O μ- Φ 3 tr tr tr Φ Φ φ Φ Φ Φ tr CO Ω hj Φ 3" O O Ω o\° Φ Ω tr 3 μ- Φ -2 Ω Ω Cu u Cu tr tr tr tr φ Cu 3" er hj Cu φ Cu 3 Φ rt ^ Cu Φ Φ Ω 3 H μ- Φ o Ω Ω u u u Cu cu μ- O Ω μ- rt rt o μ- 3 Ω O 3 3" CO 3 Cu Cu tr Φ • o 3 3 rt Ω Ω Ω Ω Ω 3 CO H) μ- μ- Ω Hi Cu O μ- rt Cu Φ rt CQ 3 o rt Φ φ φ Φ rt rt rt rt rt TJ 0- co d (- ■ 3 P- hj rt O hj d Ω O Hi hi H 3 l-S hi hj Φ Φ Φ Φ Φ TJ Φ rt co < rt . o O tr Cu o Cu H o hj O ιΩ Cu rt μ- μ- μ- hj hi l-i hi i CU Ω 3- • ? u tr μ- μ- 1 μ- rt O o\° σ rt φ o α hi CU Ω 3 d d d μ- μ- μ- μ- μ- hj μ- Φ 3 hj φ 3 Hi Cu Hi Ω μ- Hi ^< μ- CQ TJ Φ ιΩ 3 Φ 3 3 3 d d d d d rt φ o 3" CO hj 3" 0 o O ^ rt CO Φ Φ μ- H μ- 3 3 3 3 3 μ- O ιQ $, rt >Ω TJ Φ O 0 3 rt hi cu 3 μ- 3 X Q 3 Q. * Hi Ω Φ 3 3' Φ Cu *< φ 3 rt 3 * rt μ- 0 Hi Φ CU μ- Cu 3 d 3 rt u Cu ιΩ d π 3 Φ 3 hi O 3 * O Φ n O 3 3 O CO 3 rt Ω u Φ tr Ω Ω O d Cu d rt Ω ^ ιQ Φ Hi O h- 1 Hi Cu hi ^ TJ € Cu 3 * u ct <! - > φ φ Φ d Cu hj CO rt 3 O CO μ- Cu h- 1 s: O φ TJ H f- 1 tr hj μ- hj o d u H rt rt hj ■ 0 TJ Ω 3 CO d TJ rt μ- o\° Cu rt u H Cu d Φ μ- O μ- Hi 3 to 3 o O Cu 3 O 3 Φ O d (ϊ- Ω hj tr ^ CQ 3 ^ hj ^< CO Ω Cu Ω Φ CO o Cu <Ω 3 rt φ O ιΩ Ω o H tr CU 0 Φ Φ 0- rt Φ rt Ω μ- σ tr Ω Ω u l-i > Φ Cu Ω h- 1 μ- 3 * σ hi μ- hj Cu Φ hj O O 1 d μ- Ω 0 3 ><: rt o rt 3 ι-3 Ω 3 μ- d Ω Φ u • Φ φ * hj Ω Φ φ J rt TJ I- 1 Ω Ω o H >Ω u μ- 3 d φ o o μ- rt d π Ω 3 IX O 3 hi tr *< * 3 hj " : o O d a hi μ- hi < 3 3 3 H 3 o Cu 3 ?r rt Φ J Φ O Φ rt O TJ rt tip hi -• ø* Φ Cu 3 Φ μ- Φ rt u o J 3 3 Φ σ Φ o tr Hi TJ O rt Φ O ^ hj Cu μ- CO Ω rt Ω d ιΩ 3 * μ- o hi Cu hi o cu hj Ω d μ- Φ φ hj 3 TJ TJ hi Ω ^ rt ι-3 3 o Φ μ- Ω t-3 μ- Ω rt hj Ω rt Φ φ 0 3 μ- TJ CU ) O μ- O O φ o μ- σ> 1-3 3 h- 1 d 3 d rr CO o >< rt 3- O h- 1 hi <1 3 hi Cn TJ j o 3 3 rt CU i o - o O Φ d 3 O 3 Φ 3 Φ Φ φ h- 1 CO o Φ o o 3 o\o o <J ι 0- Φ CQ Φ Hi 3 H> t-3 3 μ> s: hj H φ hi 3 d CO 3 μ- rt Cu ^. O 3 φ μ- 3 μ- Q. J-- o H 1 μ- ( Ω μ- O tr μ- ιQ rt μ- Φ rt ~J 3 Φ X α H r+ 3 rt 3 O o 0- O . t-3 o H μ* d hi u d Φ Cu o • μ- μ- μ- Cn μ- 1 3" ιΩ ιΩ tr 3 Φ tV> μ> CD M ι-3 CO d CO σ> 5 3 Ω 3 3 rt O O rt 3 3 O 3 φ φ TJ > >< Φ CO o O π N 1 rt μ- rt •^ d μ- φ h- 1 3 tr o\o CO ιΩ tx O Φ hj rt n d Ω S O - 1 rt Cu rt Φ O <! U φ cn o TJ φ 3 ι 3 O " rt O H σ << 3 μ- co hj rt Φ o Ω J hi J H N 3 Φ 3" hi μ- <-o tu CO CO TJ μ- 3 μ- tr CO hj rt H O o -J l-S φ 3 ι< O Φ tr >v CO o φ Ω cu d φ o O rt rt- Hi cn o CO φ 3 rt 3 3 φ Cu 1 -J CTι d tr 3 hi 0 Hi O <! CU tr o\° rt O Cu Φ Φ d 0 CO 3 μ> o CO 3 μ- φ Hi hi Φ μ- hj Φ •*» Φ μ- CO hj H 0- cn rt M O ^ Φ CO α rr O μ- o d 3" 4 rt H -- ^ μ- 3 3 Φ μ- o H 1 3 3 H Cu O Φ 3- <£> Cu rt Cu 3 o O φ <1 hj hi Φ μ- • • " ιΩ o\o O μ- μ- 3 Ω ω rt 3 O rt tr Cu o tr ιΩ Hi O Φ 3 H φ and L-amino acid-producing mutants or strains prepared therefrom. The new ppsA gene from C. glutamicum which codes for the enzyme phosphoenol pyruvate synthase (EC 2.7.9.2) has been isolated. To isolate the ppsA gene or also other genes of C. glutamicum, a gene library of this microorganism is first set up in Escherichia coli (E. coli) . The setting up of gene libraries is described in generally known textbooks and handbooks. The textbook by Winnacker: Gene und Klone, Eine Einfuhrung in die Gentechnologie (Verlag Chemie, Weinheim, Germany, 1990) , or the handbook by Sambrook et al.: Molecular Cloning, A Laboratory Manual (Cold Spring Harbor Laboratory Press, 1989) may be mentioned as an example. A well-known gene library is that of the E. coli K-12 strain W3110 set up in λ vectors by Kohara et al . (Cell 50, 495 -508 (1987)). Bathe et al. (Molecular and General Genetics, 252:255-265, 1996) describe a gene library of C. glutamicum ATCC13032, which was set up with the aid of the cos id vector SuperCos I (Wahl et al . , 1987, Proceedings of the National Academy of Sciences USA, 84:2160-2164) in the E. coli K-12 strain NM554 (Raleigh et al., 1988, Nucleic Acids Research 16:1563-1575). Bδrmann et al. (Molecular Microbiology 6(3), 317-326) (1992)) in turn describe a gene library of C. glutamicum ATCC13032 using the cosmid pHC79 (Hohn and Collins, Gene 11, 291-298 (1980)) . To prepare a gene library of C. glutamicum in E. coli it is also possible to use plasmids such as pBR322 (Bolivar, Life Sciences, 25, 807-818 (1979)) or pϋC9 (Vieira et al. , 1982, Gene, 19:259-268). Suitable hosts are, in particular, those E. coli strains which are restriction- and recombination- defective. An example of these is the strain DH5αmcr, which has been described by Grant et al. (Proceedings of O CO > ) μ 1 H 1 cn o Cn o n O cn W tr Hi Ω ? TJ Hi o Φ Ω tr rr PL O TJ ( CO rt TJ m ω μ> t\) Φ ? m μ> co O CO μ- Hi rt Cu • d Cu 3 hj o d Hi X! O "<: tr Φ O TJ Φ Φ φ 3- TJ 3" μ- CO O • 3 3- CD Ω Cu Φ 3 3" 3 ^ Ω 3 3 o O hj Ω 3 tr Φ ιΩ Q. CO CO hj Λ φ O Φ 0 O > cΩ O Φ ^i μ- 3 ►Ω Φ Φ rt r Ω 3 s: rt 3 rt u 3 * CO H Φ μ- Ω μ- d Ω ^ -- ≤ - j φ ιΩ d rt Φ tr rt O 3 Φ O 3 * CO Cu rt μ- μ- 3 3 H <! Φ TJ 3 tr μ» 3 H — 3 Φ φ d 3 H Φ μ- rt μ- rt Φ TJ 3 μ- 3 Φ vΩ ιΩ μ- Φ 3 hj ιΩ φ Φ . — . CD rt Φ Ω hj 3 hj o CU μ- O rt 3 hj Cu ιΩ rt μ- <! hj Φ tr Q- Ω Φ Φ s: 3 CO tr CU CO Φ Ω 3 3 rt O Φ 3 CQ 3" h- 1 3 hi Φ d N Φ u D 3 Φ Φ CO 3 μ- CD CT> Cu d CO Φ μ- ιΩ μ- X d Cu Φ o rt ω φ Φ 3 Ω 3 Φ α Hi φ Φ o Ω CO — rt ιΩ μ- rt 3 tr O o TJ rt tr rt μ- Cu hj μ- " * 3 rt • > hi O 3 3 u CO — O rt o ιΩ φ α 3 ι Φ 3- O • Φ Ω rt S μ- TJ CU O Hi rt Cu > M — ^ 0 hj μ- Hi Cυ 3 Cu < < hj Φ rt Ω φ CQ μ- O 0 CO hi tr 3 3 — Hi μ- 3 }-• Cu CQ -- rt hj u tr . rt ? Cu d o rt 3 Hi φ O o rt μ- α CO rt rt ιΩ rt • 3 d μ> Φ 3 u O 3 Ω Ω " • Λ Ω- <i rt tr 3 φ 3 o 3 " CO 3 " 3 ^ Ω. tr > cn O rt 3 Cu o μ- tr rt d d Φ 3- Φ <! s: iQ CU hj Cu rt 3 σ Φ . — . Ω H Ω CO μ- Hi μ- ι hi Cu s: α rt CO H 3" Φ Ω • Φ Φ 3" d h- 1 rt Cu CO 3 T) rt h- 1 Cu Cu • • 3 • Cu Φ Φ 3 u tr M 3 Φ 3 rt Ω 3 μ- φ •< rt Ω. σ hi t o >Ω rt h- 1 CO Hi Hi CO Φ Ω m TJ o rt Ω 3 CO 3- O Φ o 3 O Φ 3 3 φ C Φ h- 1 O d Cu o rt ιΩ Φ μ- tr H hj μ- - Ω μ- Φ Hi 3 H CO μ- Ω 3 φ Φ 3 H 1 hi 3 ^ O Hi 3 3 H Φ μ- H 3 * Φ CO CO Φ Φ hj O Φ co Φ rt Φ 0- 3 > 1 Hi 3 O • 3 D Φ 3 CO φ 3 Ώ s ^ -» CQ Λ φ Φ CO rt -J Cu o μ- 3 Cu 3 <Ω ιΩ < Φ s: O hj Φ O Cu O CO O Cu 3 Φ d Ω, α Φ μ- O o Cn h- 1 hj 3 rt Φ 3 ιΩ • Φ 3 O rt tr 3 * Φ 3 J 3 1 O Hi CD Q hi d iQ φ μ- ■ Ω 3 Hi -J μ- 3 TJ " d φ d 3 0 Cu μ- μ- 0 CO rt 0 Cu ^ Ω o d 3 to 3 d Ω Cu CU u Φ rt 3 Φ rt Φ rt • 3 Ω Ω s: d 3 CO O O TJ ?r M φ Ω rt ιΩ Φ rt H to ^ ~. * * rt μ- H rt X Cu X μ- φ 3 ^ 3 h- 1 D M • hj φ 3 Φ Cυ CO 3 tr 0 Ω μ> μ- hj 2 CU Cu TJ 3 Ω O μ> Ω rt 3 μ- tr !θ J-- O ^ -. μ- Ω CO rt Ω Φ 3 μ- Ω μ- o μ j Φ μ- 3 * 3 s: O H μ- μ- 3 Φ ιΩ 1 ιΩ 3 Ω Φ Φ o Φ Φ Φ CO 3 3 o Cu hi Ω Cu • o Cu Q- Φ 3 3 ιΩ Φ H CD H d Ω CO Hi d α 3 hi 3 Hi Ω rt 3 hj ^< Φ CO ιΩ O 3 D d -J Cu Ω > Cu u ^ CO Ω •~^ Od μ- d tr CO cu <Ω O "* d O φ TJ rt 3 M Ω 3 3 0 rt d S φ — Φ 3 Ω \ 3 u Ω Φ o TJ Cu h- 1 M Cu ώ hi Hi 3 Cu . — . Φ μ- Cu Hi 3- Cu Cu μ- CQ ^ 3 cu o Ω 3 Cu μ- 3 CU α hi rt 3 d O O O 3 O μ- α H rt Φ CO rt 1 rt 3 hj rt ιΩ O o. O CO hj 3 Φ μ- φ rt d • μ- CD Hi Ω CO ^ 3" l 5? ^ μ- tf 3" μ- Φ Hi φ rt Hi H 3 3 Φ 3 Ω CD CO Φ J3 3 μ- < co 3 cu μ- Φ O o 3 μ- hj CO Cu hi o o Ω μ- p. μ* d CO CO > 50 μ- 3 Φ Cu CQ Φ rt O CO <! 3 μ- CQ 3 ιΩ <! CO h-' O φ 3 ^ 3 — d Ω Φ ω H rt Ω tr * * O CO φ rt • 3 Φ h- 1 Cu O φ CD 3 3 Cu — rt μ- O tr μ- μ- Ω. rt φ CU Ω 3 Φ 3 TJ ^ rt Hi Λ O O Ω tr 3- ι-3 μ- s: • H α Φ TJ Φ Ω o Φ O CO 50 rt O hj H rt to hi Ω μ- d CO μ- *< Cu 3" CQ 3 ^ Φ CO Cu H CU 3 O l-i Cu -J Φ 3 O 3 rt 3- Φ o μ- <! O φ Cu M O Φ μ- hj hj o μ- Cu Ω CO μ- ιΩ Φ rt rt μ- Φ rt 3 Φ M 3 N3 rt u Ω to Ω IΩ 3 hi α --. Cu rt Φ Cu 3 μ- 3 Φ Φ lO Ω Ω . CO 3 * Hi Cu 3- ^ ~ ^ φ 3 * hi <! - μ- CO H 1 3 tr d co Cu d μ- cu Φ O H Φ Φ d 3 Ω s CQ CU Φ J-» σ d o CD Cυ rt μ- O Ω rt 3 Hi 3 H CO 3 D ,Ω H μ- o Ω φ Φ μ> 3 CO • • Ω Φ μ- Hi CD Φ h-> μ- Hi rt Cu CO O μ- D CO d 3 rt 3 3 O rt CU .E- CO rt Cn Cu rt O rt Ω μ- o d μ- rt H 3 s: rt 3 Φ Φ tr o CO α tr hj " μ- α Cυ Ω — Cu N Hi hi μ- o 3 3" μ- O 3 rt φ rt Φ o Ω ιΩ en Φ Φ tr O Cυ -- ^ 3 Φ rt μ- o Cu CU O μ- rt • Ω 3- hj Cu μ- CQ a * IV) CO Cu CO 3 • h- 1 CO J-- -> Cu tr rt 3 hj Cu • Ω d Φ O 3 Ω rt CO μ 1 d rt 1 ■ < ιΩ φ 3 cn • O σ rt Φ •< CO Φ CU Ω 3' Φ α o μ- d Hi μ> Ω Φ cn • μ- as. d Φ 3 TJ hj 3 3 μ- l-> 3 O CQ hi Ω. φ o o n 1 tr Ω, J-. o Hi 0- Cn — hi Φ H 3 o μ- o. rt tr Hi φ 3 hi Hi *« cn Hi σ o ω 1 Q 3 Hi O 0 hh £ 3 Cu •<: rt u > H as. Φ Cu O rt hi tr φ H O rt tr rt μ 1 CO μ- Ω cn 3 M d Φ φ rt μ- Φ Hi rt tr φ 0 tr CO rt Cu 0-- Φ 3 μ- tr Ω o 3 ^ Φ φ H) Φ tr 3 CD O 0- 3 Φ tr hi Cu Φ 3 CD Hi 1 77:237-251 (1989)), in Sahin-Toth et al . (Protein Sciences 3:240-247 (1994)), in Hochuli et al. (Bio/Technology 6:1321-1325 (1988)) and in known textbooks of genetics and molecular biology. Amino acid sequences which result in a corresponding manner from SEQ ID No. 2 are also a constituent of the invention. In the same way, DNA sequences which hybridize with SEQ ID No. 1 or parts of SEQ ID No. 1 are a constituent of the invention. Finally, DNA sequences which are prepared by the polymerase chain reaction (PCR) using primers which result from SEQ ID No. 1 are a constituent of the invention. Such oligonucleotides typically have a length of at least 15 nucleotides. Instructions for identifying DNA sequences by means of hybridization can be found by the expert, inter alia, in the handbook "The DIG System Users Guide for Filter Hybridization" from Boehringer Mannheim GmbH (Mannheim, Germany, 1993) and in Liebl et al. (International Journal of Systematic Bacteriology (1991) 41: 255-260) . The hybridization takes place under stringent conditions, that is to say only hybrids in which the probe and target sequence, i. e. the polynucleotides treated with the probe, are at least 70% identical are formed. It is known that the stringency of the hybridization, including the washing steps, is influenced or determined by varying the buffer composition, the temperature and the salt concentration. The hybridization reaction is preferably carried out under a relatively low stringency compared with the washing steps (Hybaid Hybridisation Guide, Hybaid Limited, Teddington, UK, 1996) . A 5x SSC buffer at a temperature of approx. 50°C - 68°C, for example, can be employed for the hybridization reaction. Probes can also hybridize here with polynucleotides which are less than 70% identical to the sequence of the probe. Such hybrids are less stable and are removed by washing under stringent conditions. This can be achieved, for example, by lowering the salt concentration to 2x SSC and optionally subsequently 0.5x SSC (The DIG System User's Guide for Filter Hybridisation, Boehringer Mannheim, Mannheim, Germany, 1995) a temperature of approx. 50°C - 68°C being established. It is optionally possible to lower the salt concentration to O.lx SSC. Polynucleotide fragments which are, for example, at least 70% or at least 80% or at least 90% to 95% identical to the sequence of the probe employed can be isolated by increasing the hybridization temperature stepwise from 50°C to 68 °C in steps of approx. 1 - 2°C. Further instructions on hybridization are obtainable on the market in the form of so-called kits (e.g. DIG Easy Hyb from Roche Diagnostics GmbH, Mannheim, Germany, Catalogue No. 1603558) . Instructions for amplification of DNA sequences with the aid of the polymerase chain reaction (PCR) can be found by the expert, inter alia, in the handbook by Gait: Oligonucleotide Synthesis: A Practical Approach (IRL Press, Oxford, UK, 1984) and in Newton and Graham: PCR (Spektrum Akademischer Verlag, Heidelberg, Germany, 1994) . It has been found that coryneform bacteria produce amino acids in an improved manner after over-expression of the ppsA gene. To achieve an over-expression, the number of copies of the corresponding genes can be increased, or the promoter and regulation region or the ribosome binding site upstream of the structural gene can be mutated. Expression cassettes which are incorporated upstream of the structural gene act in the same way. By inducible promoters, it is additionally possible to increase the expression in the course of fermentative amino acid production. The expression is likewise improved by measures to prolong the life of the m- RNA. Furthermore, the enzyme activity is also increased by preventing the degradation of the enzyme protein. The genes or gene constructs can either be present in plasmids with a varying number of copies, or can be integrated and amplified in the chromosome. Alternatively, an over- expression of the genes in question can furthermore be achieved by changing the composition of the media and the culture procedure. Instructions in this context can be found by the expert, inter alia, in Martin et al. (Bio/Technology 5, 137-146 (1987)), in Guerrero et al. (Gene 138, 35-41 (1994)), Tsuchiya and Morinaga (Bio/Technology 6, 428-430 (1988)), in Eikmanns et al. (Gene 102, 93-98 (1991)), in EP 0 472 869, in US 4,601,893, in Schwarzer and Puhler (Bio/Technology 9, 84-87 (1991), in Reinscheid et al. (Applied and Environmental Microbiology 60, 126-132 (1994)), in LaBarre et al. (Journal of Bacteriology 175, 1001-1007 (1993)), in WO 96/15246, in Malu bres et al. (Gene 134, 15 - 24 (1993)), in JP-A-10-229891, in Jensen and Hammer (Biotechnology and Bioengineering 58, 191-195 (1998)), in Makrides (Microbiological Reviews 60:512-538 (1996) ) and in known textbooks of genetics and molecular biology. For enhancement, by way of example the ppsA gene according to the invention was over-expressed with the aid of episomal plasmids. Suitable plasmids are those which are replicated in coryneform bacteria. Numerous known plasmid vectors, such as e.g. pZl (Menkel et al., Applied and Environmental Microbiology (1989) 64: 549-554), pEKExl (Eikmanns et al., Gene 102:93-98 (1991)) or pHS2-l (Sonnen et al., Gene 107:69-74 (1991)) are based on the cryptic plasmids pHMl519, pBLl or pGAl. Other plasmid vectors, such as e.g. those based on pCG4 (US-A 4,489,160), or pNG2 (Serwold-Davis et al., FEMS Microbiology Letters 66, 119- 124 (1990)), or pAGl (US-A 5,158,891), can be used in the same manner. CO CO ) rv> μ> cn o Cn o Cn o Cn rt U3 3 t "1 H μ- 1 Cu co * — ^ _ eu rt o 1 s Φ rt rt Ω Cu -) DO O IV) TJ -J Φ Ω TJ O Cu d Cu rt J tr H 3 φ OS. μ> μ> μ- hj μ- X hj 3' O h- 1 O μ- hi cn O CO μ> X o TJ μ» h-' CO 3 " Φ • : H Cu cu 3 co CD CD • Cu Ω Cu Cu Φ 3 • d 0 O CD 50 CD cu -> CU Φ CD • φ TJ O Cu Ω Φ 3 Cu O Ω I CO CO 3 H 3 3 li ¬ ^ H H" 3 • • ) ,-«. CO 3 μ- CO hj D D- μ- CO CQ TJ o μ- 0- rt H CO CD CO —. O o TJ O eu μ» 3 O μ- O . μ> O TJ — 3 O as. ^ — . μ- Φ 3 φ H Φ 3 α 0 αs> — ~— ' Hi σ Hi Φ μ- D Cu ιO 3 t ) μ- 1 CD •— - h- 1 ^ μ- 3 - — Hi μ- 3 •< 3 O μ- rt CO — — ' TJ O μ- φ O O 3 CO -> ^ ι cn 1 CD — Φ D- • - — TJ Cu μ- s: CL rt CO N rt ≤: CO ^ TJ hj o hi μ- CQ en •«• Φ m s. tr J CO Ω μ- O μ- * Cu μ- 0 .--. Cu μ < 3 H 3 hj • ^ O 3 CO o — d <! H Hi - 1 eu rt < CO co 3 Ω o O h- 1 3 D μ- Cu 0 LT Cu Φ rt Hi IV ) 1 TJ ~~ J J rt Φ 3 0 μ- ^ rt 3 ^ φ Φ Φ μ- 3 Ω <! CD a d φ rt >Ω > < rt a. 3 * Q O CO o ^ t O Ω H Φ Cu μ- Ω CO 0. O φ CD 3 a μ- ><: μ- φ Φ rjo as. CC as> a 3 rt rt a O o rt rt TJ 0 O T hi a-. H μ- O O O O 3 cu o *«• ,-~. TJ CO TJ 0 O 3- a 3 3- O ■ tr Hi o μ- μ- 3 — Cu Ω S 3 cn Ω 3 rt ιΩ Φ Ω μ> o Q 3 CO rt hi μ- d Cu σ Φ H o Hi rt rt φ — d cu μ- o 3 ^ • i φ rt cn t- 1 3 J t? o o o TJ 3 Φ tr O CO Cu o O Φ Ω 3 Ω Cu Cu: Cu 3 as. Φ O cu O d S tr H 1 μ- € 1 Φ •< Cu TJ 3 rt 3 < tr hi hi Hi ι-3 μ- Φ H 1 hi as. 3 1 3 1 3 tr 3 μ- 3 μ- s: 3 * Cu tr φ Cu O Φ Cu O Φ Φ 3" 3 .. μ- 1 a cu H o ^ -, μ- φ Ω m μ- CL tr Cu TJ φ 3 ^< Hi 3 Hi Φ 3 tr cn H Φ rt o cn 3 hi O o Ω rt cu 3 a 3 μ- rt μ- tr rt rt li ¬ μ- cn o O CO as. cn . μ- . tr 3- rt <! Φ rt o Ω Φ Φ TJ u tr rt « * Φ o φ 1 Φ 3 Hi O o μ> ro . ,— , T TJ 3 O μ- μ- CO φ Hi tr H Cu 3 Φ - H eu CO O rt- Φ tr -~ ιΩ Φ as. μ» hj tK o ι Ω a o S Ω ιΩ O o H Ω Φ rt H tr O Ω cn rt O φ 1 ^ . » hj CO CD O μ> 3 H Cu * * 3 o hi hi s: cu • ω rt Φ Cu tr 3- μ- ιΩ H D Cu - • CO 3 CD 3 CD d 3 3 μ- cu tr H Ω μ- μ- CL >Ω φ O >< μ- M O eu as. CD Cu "* s- φ 3 Φ rt- rt O 3 tr rt μ- Φ O Ω Φ 3 3 tr . — . • Ω- ιΩ 3 IV) ~J CD hi CD — ι O li- cu hi tr hi Φ φ μ- Ω Φ ^ d μ- Cu 3 H o <! cu Cu Φ TJ — O CO Ω. CD • Cu tr 3 φ Φ 3 a O 3 Hi μ- 3 3 Φ Φ μ- H 3 3 CD ^ -» O d h- 1 . * ■ •— ' CO Cu μ- TJ CU li- 3 d o u rt CO o s a "* CD Hi ri- μ- as. — Φ — Ω ,—. h- 1 Ω * Ω 3 Cu rt H O Hi hj TJ Cu μ- d ιΩ CO . — . as. TJ eu Hi ι-3 Cn rt- ^ o O CO • d μ- o TJ h-> Hi μ- 3" rt Hi Cu ιΩ 3 μ- O w GO Hi — J Ω 3 μ- tr μ> d H Ω -• 3 Ω 3 H" c 3 Φ tr rt tr H Φ rt d S μ- μ- o * — h- 1 0 μ- φ φ o TJ Cu TJ H TJ 3 * cu TJ μ- s hj rt Φ CU 3- μ- rt 0 Λ μ- CQ μ- o O hi • μ- 3 Ω 1 M I- 1 o 3 O Cu: CO rt * Hi μ- 0 J H 3 Φ o μ- d d 3 Ω " . rt Φ l_J. d TJ as. S • 50 Cu H Hi μ- J φ φ μ- Ω φ hj 3 μ- CO Ω CO Φ ιΩ hj hi H3 Φ φ S a d 3 μ- h- 1 n μ> ^ ® h- 1 CU Φ o o rt Ω H rt O O 3 Ω < d CQ φ 0 Φ Ω X Φ ιΩ Q cu μ 1 CO rt hj \ to μ- Φ cu o CU J Ω hj 0 μ- 3 h- 1 Hi rt CQ Ω tr Ω 3" Cu rt cu CU tr to cn ^ -. C-i h- 1 O μ- H3 CQ 3 rt tr 3 Φ Φ Φ rt rt CU O μ- rt O μ- £T 3 3 tr 3 rt >< rt 3 *— O o d Hi o Φ φ μ- ιΩ μ- μ- TJ CO Cu hj 3 * H H O l-i 3 0 3 O J o Ω. μ- 3 * μ- Ω d 3 3 fi- Ω σ cu Φ o O - 1 Ω CO O Ω μ- Φ 3 Cu r h- 1 O h- > CL O o φ Ω. o 3 ^ H do ^ 3" -> 3 3 Φ tr d μ- Ω CO o rt • μ- μ- o O φ O M 3 o 3 hj hi 3 μ- CU 3 Φ ^ Φ O •% H O μ- Ω. μ- <! " 3 3 ιΩ O ιΩ 3 3 <! d Cu O S H 0 o O ιΩ O Hi rt Cu o Φ Φ Cu μ- ι ^ Hi < μ- l_|. rt Φ TJ 3 H 1— | h- 1 Cu • h- 1 <! CQ μ- Hi ^ σ 3 cu φ Ω H Ω rt Ω "< tr o μ- Q d H Ω 1 TJ w o μ- Cu IV) ^ H hj U3 Cu rt Q •6 3 o a . O Φ rt CQ ^ o ιΩ tr μ- TJ Hi o J u Φ hj 3 o -J CD o CL CU 3 O O Hi <! ιΩ μ- ιΩ Ω rt cn CO Φ h- 1 T p. μ- o a • ; rt ^ — , Ω tr o 50 o 3 φ o rt ><: O li ¬ 3 ^ m 3 φ rt CO hi CO Φ (-f- Ω O Φ O rt μ- 1 Φ Φ 3 Φ hi Ω tr TJ Ω, eu tr 1 3' 3 CO μ- Hi li- S H Cu 3 3 Λ H < < o μ- Φ Cu li- ^ € H d μ- tr φ co μ- φ Ω o Φ s; . , o o *• Φ CO J 3 tr H 1 3 hj Ω cu Ω 3 "< rt O cn Φ 3 H 3 hi - O Cu tΩ μ- Φ o IV) O Ω Φ Cu i- > << CO rt CO rt cn cn H li ¬ μ- hi μ- TJ μ- Φ Φ cn Ω eu 3 φ ^ O μ- o S! μ> Cu Ω a 3 3 Φ I σ eu tr 0 Φ Ω hj o 1 1 tr 3 CU Ω. o Cu 3 3 ^ H as. 00 hj Cu φ hj 1 CO cu μ- Φ hj Ω. Cu d Φ • ^ cπ as. Φ - 1 μ- rt μ> Φ h- 1 o o 3 rt Cu CO μ> n Ω Ω- rt μ» 3 1 H 3 3 * CO μ- tr CQ 0 Hi 3 3 o IV) tr μ- rt CD CU μ- a ^ hi M a Φ O Hi φ O CO μ> 3 CD H CQ CO n CD Hi Cu Hi IV) ω o Φ Hi rt Φ μ* rt D μ. O M Φ o o CO rt O 0 rt H 1 hi rt- hj Hi hj optionally regulatory proteins, in addition to the ppsA gene. Thus, for the preparation of L-amino acids, in addition to enhancement of the ppsA gene, one or more genes chosen from the group consisting of • the dapA gene which codes for dihydrodipicolinate synthase (EP-B 0 197 335), • the gap gene which codes for glyceraldehyde 3-phosphate dehydrogenase (Eikmanns (1992) , Journal of Bacteriology 174:6076-6086), • the tpi gene which codes for triose phosphate isomerase (Eikmanns (1992), Journal of Bacteriology 174:6076-6086), • the pgk gene which codes for 3-phosphoglycerate kinase (Eikmanns (1992), Journal of Bacteriology 174:6076-6086), • the zwf gene which codes for glucose 6-phosphate dehydrogenase (JP-A-09224661) , • the pyc gene which codes for pyruvate carboxylase (DE-A-198 31 609) , • the mqo gene which codes for malate-quinone oxidoreductase (Molenaar et al., European Journal of Biochemistry 254, 395-403 (1998)), • the lysC gene which codes for a feed-back resistant aspartate kinase (Accession No.P26512), • the lysE gene which codes for lysine export (DE-A-195 48 222), • the horn gene which codes for homoserine dehydrogenase (EP-A 0131171), • the ilvA gene which codes for threonine dehydratase (Mδckel et al., Journal of Bacteriology (1992) 8065- 8072)) or the ilvA(Fbr) allele which codes for a "feed back resistant" threonine dehydratase (Mδckel et al., (1994) Molecular Microbiology 13: 833-842), • the ilvBN gene which codes for acetohydroxy-acid synthase (EP-B 0356739), • the ilvD gene which- codes for dihydroxy-acid dehydratase (Sahm and Eggeling (1999) Applied and Environmental Microbiology 65: 1973-1979), • the zwal gene which codes for the Zwal protein (DE: 19959328.0, DSM 13115) , can be enhanced, in particular over-expressed. It may furthermore be advantageous for the production of L- amino acids, in addition to the enhancement of the ppsA gene, for one or more genes chosen from the group consisting of • the pck gene which codes for phosphoenol pyruvate carboxykinase (DE 199 50 409.1; DSM 13047), • the pgi gene which codes for glucose 6-phosphate isomerase (US 09/396,478; DSM 12969), • the poxB gene which codes for pyruvate oxidase (DE: 1995 1975.7; DSM 13114), • the zwa2 gene which codes for the Zwa2 protein (DE: 19959327.2, DSM 13113) to be attenuated, in particular for the expression thereof to be reduced. The term "attenuation" in this connection describes the reduction or elimination of the intracellular activity of one or more enzymes (proteins) in a microorganism which are coded by the corresponding DNA, for example by using a weak promoter or using a gene or allele which codes for a corresponding enzyme with a low activity or inactivates the corresponding gene or enzyme (protein) , and optionally combining these measures. By attenuation measures, the activity or concentration of the corresponding protein is in general reduced to 0 to 75%, 0 to 50%, 0 to 25%, 0 to 10% or 0 to 5% of the activity or concentration of the wild-type protein or of the activity or concentration of the protein in the starting microorganism. In addition to over-expression of the ppsA gene it may furthermore be advantageous for the production of amino acids to eliminate undesirable side reactions (Nakayama: "Breeding of Amino Acid Producing Micro-organisms", in: Overproduction of Microbial Products, Krumphanzl, Sikyta, Vanek (eds.), Academic Press, London, UK, 1982). The invention also provides the microorganisms prepared according to the invention, and these can be cultured continuously or discontinuously in the batch process (batch culture) or in the fed batch (feed process) or repeated fed batch process (repetitive feed process) for the purpose of production of amino acids. A summary of known culture methods is described in the textbook by Chmiel (Bioprozesstechnik 1. Einfϋhrung in die Bioverfahrenstechnik (Gustav Fischer Verlag, Stuttgart, 1991) ) or in the textbook by Storhas (Bioreaktoren und periphere Einrichtungen (Vieweg Verlag, Braunschweig/Wiesbaden, 1994)). The culture medium to be used must meet the requirements of the particular strains in a suitable manner. Descriptions of culture media for various microorganisms are contained in the handbook "Manual of Methods for General Bacteriology" of the American Society for Bacteriology (Washington D.C., USA, 1981). Sugars and carbohydrates, such as e.g. glucose, sucrose, lactose, fructose, maltose, molasses, starch and cellulose, oils and fats, such as e.g. soya oil, sunflower oil, groundnut oil and coconut fat, fatty acids, such as e.g. palmitic acid, stearic acid and linoleic acid, alcohols, such as e.g. glycerol and ethanol, and organic acids, such as e.g. acetic acid, can be used as the source of carbon. These substances can be used individually or as a mixture. Organic nitrogen-containing compounds, such as peptones, yeast extract, meat extract, malt extract, corn steep liquor, soya bean flour and urea, or inorganic compounds, such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate, can be used as the source of nitrogen. The sources of nitrogen can be used individually or as a mixture. Phosphoric acid, potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding sodium- containing salts can be used as the source of phosphorus. The culture medium must furthermore comprise salts of metals, such as e. g. magnesium sulfate or iron sulfate, which are necessary for growth. Finally, essential growth substances, such as amino acids and vitamins, can be employed in addition to the above-mentioned substances . Suitable precursors can moreover be added to the culture medium. The starting substances mentioned can be added to the culture in the form of a single batch, or can be fed in during the culture in a suitable manner. Basic compounds, such as sodium hydroxide, potassium hydroxide, ammonia or aqueous ammonia, or acid compounds, such as phosphoric acid or sulfuric acid, can be employed in a suitable manner to control the pH of the culture. Antifoams, such as e.g. fatty acid polyglycol esters, can be employed to control the development of foam. Suitable substances having a selective action, such as e.g. antibiotics, can be added to the medium to maintain the stability of plasmids. To maintain aerobic conditions, oxygen or oxygen-containing gas mixtures, such as e.g. air, are introduced into the culture. The temperature of the culture is usually 20°C to 45°C, and preferably 25°C to 40°C. Culturing is continued until a maximum of the desired product has formed. This target is usually reached within 10 hours to 160 hours. Methods for the determination of L-amino acids are known from the prior art. The analysis can thus be carried out, for example, as described by Spackman et al. (Analytical Chemistry, 30, (1958), 1190) by ion exchange chromatography with subsequent ninhydrin derivation, or it can be carried out by reversed phase HPLC, for example as described by Lindroth et al. (Analytical Chemistry (1979) 51: 1167- 1174). The process according to the invention is used for fermentative preparation of amino acids. The present invention is explained in more detail in the following with the aid of embodiment examples. The isolation of plasmid DNA from Escherichia coli and all techniques of restriction, Klenow and alkaline phosphatase treatment were carried out by the method of Sambrook et al. (Molecular Cloning. A Laboratory Manual (1989) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA) . Methods for transformation of Escherichia coli are also described in this handbook. The composition of the usual nutrient media, such as LB or TY medium, can also be found in the handbook by Sambrook et al. Example 1 Preparation of a genomic cosmid gene library from Corynebacterium glutamicum ATCC 13032 Chromosomal DNA from Corynebacterium glutamicum ATCC 13032 was isolated as described by Tauch et al. (1995, Plasmid 33:168-179) and partly cleaved with the restriction enzyme Sau3AI (Amersham Pharmacia, Freiburg, Germany, Product Description Sau3AI, Code no. 27-0913-02) . The DNA fragments were dephosphorylated with shrimp alkaline phosphatase (Roche Diagnostics GmbH, Mannheim, Germany, Product Description SAP, Code no. 1758250) . The DNA of the cosmid vector SuperCosl (Wahl et al. (1987) Proceedings of the National Academy of Sciences USA 84:2160-2164), obtained from Stratagene (La Jolla, USA, Product Description SuperCosl Cosmid Vector Kit, Code no. 251301) was cleaved with the restriction enzyme Xbal (Amersham Pharmacia, Freiburg, Germany, Product Description Xbal, Code no. 27- 0948-02) and likewise dephosphorylated with shrimp alkaline phosphatase. The cosmid DNA was then cleaved with the restriction enzyme Ba HI (Amersham Pharmacia, Freiburg, Germany, Product Description BamHI, Code no. 27-0868-04) . The cosmid DNA treated in this manner was mixed with the treated ATCC13032 DNA and the batch was treated with T4 DNA ligase (Amersham Pharmacia, Freiburg, Germany, Product Description T4-DNA- Ligase, Code no.27-0870-04) . The ligation mixture was then packed in phages with the aid of Gigapack II XL Packing Extract (Stratagene, La Jolla, USA, Product Description Gigapack II XL Packing Extract, Code no. 200217) . For infection of the E. coli strain NM554 (Raleigh et al. 1988, Nucleic Acid Research 16:1563-1575) the cells were taken up in 10 inM MgS0 and mixed with an aliquot of the phage suspension. The infection and titering of the cosmid library were carried out as described by Sambrook et al. co IV) IV ) μ 1 μ» o cn o cn o Cn J μ» φ ^ μ- S to O IV) ". X hj IV) μ j hi 3 Cu CU φ -J hj Cu > O ω φ Φ Ω 3 Λ 1 φ hj D Ω .. Ω μ- d d Q 1 d o μ- tr CO Φ CO rt σ tr Cu H Φ CO tr o CD Φ OS- H d CU h- 1 O 3 en d hj ^ P. CO o hi rt O Ω CO H — μ- 1 TJ ιΩ φ ? μ- 1 Q ^ s: 3 ~J 0 a o 3 o O lΩ — hi 0 φ <Q JS. rt H CQ CU Ω o H li- • — Q 3 1 Φ μ- rt Φ CL <! • Φ Φ Ω O 3 Φ hi Φ Cu Φ H d Hi rt CL 3 K CO h- 1 Ω m 3 o h- 1 O CU 3 TJ • rt ST Cu Φ eu rt . — . 3 μ- H O Φ 3 H 1 hi tr (i- m • ιΩ μ- . — . hi * h- 1 φ tr eu tr 3 μ> μ- 1 ** co Ω φ d . rt iQ CD TJ μ- 3 o O N ι TJ σ O CU M 3" H s: SG CD Φ Cu H Φ 3 rt • 3 ^ μ- CU *«» hj rt O μ- μ- μ- φ μ- rt hj O μ- a 3 3 o Ω lico 3 * σ 2 1 o d iQ ιΩ 3 O o o μ» 3 Ω • • eu eu H HI hj H rt TJ h- 1 μ- h- 1 μ- OS. ' — Φ s: O h- 1 • vΩ ^ Ω Cu Hi D eu :> o eu - 1 d CO Φ rt Ω rt μ- 1 rt μ- rt h- 1 rt CO Φ CU CU H D μ- ιΩ * CU Ω 3" Ω a tr f Cu CD 0 eu φ hj CU Φ l-S o φ μ- OS. 3 O hj μ- o hj 3 3 φ o O H Ω TJ d eu •<: 3 3 h- 1 μ- 0 rt rt rt D n. μ- ,—. > O Φ O μ- o o x M X TJ 3 a 3 O o hj Hi cn s rt tr 3 μ- μ- 3 3 * S O d cu μ- 3 o α O S H hi X ιΩ d CO t- f s Ω O s φ 3 rt • • li- Hi Cu CO eu μ- fύ μ- Cu d H 3 3 Φ Ω s; Ω hi > Cu Cu x eu d 3 ^ -« hi cu μ- Φ CO ( Ω ιΩ eu Ω Ώ o O eu tr 1 3 ^ Cu - 1 Φ H tr tr cu a Φ H CO CU μ- rt . do Φ tr Φ 3 J 3 o 3 * μ- μ- o co rt hi . — . o rt μ- Φ o 3 H Ω o o -i o * ^ 3 rt iΩ eu H Ω- Φ O tr* Φ rt μ- μ- d 3 a • μ> Φ Ω o tr 3 Ω 3 D rt tr hi Φ rt O O • CD rt « * • 0- rt X TJ o Φ tr 3 " H hj tr φ O μ- 3 ^ ιΩ IV) μ» n o cn o Cn ι-3 Hi H to X m TJ μ> rt H -. cu Cu Ω > . H INI α (i- !θ Ω ι-3 < 00 3" hj 3 tr Φ μ- tr ISI as. r 3" S > TJ 3 Φ J s μ- 3- μ- ϋ ) sr μ- -J Φ eu Cu φ to rt Φ φ • • Φ Φ Φ w H 3 a hi J φ 3 to O Φ Cu H Φ H • • 3 M Φ tr hj N> μ- H O 50 3 H 3 • ~ ιΩ H 0 as. J φ * hi Cu 0 0 μ> O hi rt a O cu Cu μ- 3 Φ l a Φ μ- TJ H cn TJ O Φ hi rt o μ» rt eu φ T) d rt 3 3 Φ 50 hi ^ μ- 3 φ μ- O as. CQ o μ- CO Ω sr 3 1 CU X hi H Ω μ- Cu ■ < a 50 3 ^ a - a Cu ιΩ Cn > Hi Q d 3 * φ TJ a IV) a O μ- rt TJ μ- eu TJ Φ O • : 1 h- 1 ^ » d φ CO φ CQ li- CO tr ■ <: to a 3 H o SG 0 3 as. ιΩ H 1 o rt X r+ hi μ> 3 Φ Cu 3 3 o O Ξ μ- V 3 Os. O X μ- d μ- cn Φ O Hi μ- h- 1 3 Φ μ- — Λ a O H μ- Cu o tr • • Ω • h- 1 rt a as. 3 CD 3 js. μ) H < TJ d rt O • Φ O CO O rt o Φ cn Φ a • • O Φ cn uq • • TJ 1 eu <! hi φ O •<: a rt- s. Φ Ω Φ X J μ> tr > Cu rt Φ o 3 -o μ- o d O eu cn a tr 3 μ- H D Ω tr Φ 3 μ> TJ CQ μ- H vΩ Ω Ω 3 H 1 co Hi O rt 3 cu O μ- eu ^ rt Φ o eu O CU d H CO <1 O H Φ φ IV ) φ Φ μ- (- ■ 1 3 μ- tr TJ — 3 a 3 Ω 1 o μ- Φ μ- Cu H O 3 rt a 3 3 • cn 3 Ω Cu a φ Φ d μ- 1 M iQ o CQ O 3 a 3 φ • ^ tr O O Φ rt H X O Ω φ CO H rt 3 eu eu ► μ» Φ m ^ cn rt H tr 0 ) μ- TJ TJ H o H 1 Cu Φ X TJ li- 3 d m ^ ~. Φ O Φ 3 Φ rt rt Hi Cu φ rt 3 a Φ CD Cu Cu s Φ Ω O tr TJ H CD — Hi H eu μ- sr eu o μ- o μ- • H -J Ω 3 50 hi φ Φ hi 3 CD 3 3 W O rt hj hj rr a ^ — . Ω Φ 1 f*T o • Ω o > Λ O μ- O X rt μ- • μ- 3 cn φ CQ μ- Φ to O o CU tr Φ rt H d CO a 3 μ- 3 * 3 — o o a eu "* a li- a CU • ιΩ rt hi 3" CU Φ Φ d CU rt Φ Cu • H O Φ O Cu μ- CO Φ Cu ^ 3 3 TJ O r 3 3 * rt o Hi 3 o TJ X Φ a 3 CQ ι-3 μ- Hi μ- Ω Cu rt O d 3 μ- Hi tr Ω d hj tr CO Λ Φ <Ω φ tr . — 3 hj a μ- hj H Ω 3 Cu 0 sr o rt ^ r o μ- Φ d 3 Φ Φ O Cu Φ 3 CU 3 o rt 3 Φ rt sr rt Ω Λ Φ ^ hi tr O a 3 hi \ vΩ rt 0 O Φ a μ- φ o φ sr d 3 Φ H μ- 00 I- 1 to μ- • ^ μ- μ- 0 3 CO CD N 3 μ- Φ Ω μ» ιΩ φ 3 cn X TJ CQ μ- H o Ω Ω Hi 3 Φ φ cn H Φ 3 x 3 Φ CD μ- a a Φ M hj o Φ 3 αs. μ- Cu r+ ►Ω o Φ O t" 1 Cu Ω CO o μ- H d eu Cu o Φ > Ω h- 1 d o Ω Ω t) o CO Φ μ- cn 3 rt <i 3 Φ > 3" Ω Ω tr CO Ω eu O φ O μ- Hi co * O μ- d J φ H rt > o O μ- rt a 3 . — , 3 3 Cu Ω CQ Cu a Ω rt TJ "* •< μ- Φ a μ- Ω Ω TJ LT • ιΩ O Cu tr O 3 3 Cu d h- 1 tr h- 1 h- 1 O >Ω Os. Λ O o Cu o μ- H μ- Cu en h- 1 o 3" d Cu Cu φ Φ μ- Ω Cu 3 Φ ^ d 3 a Hi 3 O 3 hi h- 1 x o Ω h- 1 Ω H μ- 3 φ Φ 3 H Φ 50 CO Φ ιΩ a Cu φ Φ X " «< O Ω a H μ- X S 3 Φ 3 O d 3 . — . Cu a a 3 φ O 3 O TJ 3 a Φ φ Φ Ω CQ Cu * eu X Ω rt tH 3 μ- μ- rt Φ > H w eu Φ H μ- μ- Φ Ω 3 Cu rt Φ μ- rt Cu μ- Ω CO μ- Λ Ω O μ- 3 3 Φ Φ rt ' 3 CU Ω o ιΩ CO Ω 3 3 3" 3 3 3 d μ- Ω 0 s Ω Φ ιΩ H o Hi φ 3 H 1 3 o Φ X d Φ a Φ CO Ω Ω rt H Ω hi H Ω O O O O to Ω Cu 0 3 CQ CO >< Φ CU hi CQ ^ tr a CO CU • 3 X Cu TJ TJ w μ- O d Ω O O s: M hj O li- μ- μ- Ω Φ H Φ Ω TJ φ a O φ V Φ rt μ- H J Cu rt 3 μ- rt H CD CO μ- 3 O J O Φ a φ rt . — . μ- tr a iQ Φ μ- O μ> a > H hi Ω CO 3 3" t ) Φ 0 rt CO 3 Cu Φ O X CO to hi α φ 0 0 φ d to CD a hj ^ Hi • • rr Ω h- 1 a rv> Cu Cn • iQ Φ J 3 Hi Cu to rt • • φ hj μ» O Φ • o O Cn Φ Cu 3 cu rt hi μ- tr o CO O o CO o o 3 a o hi μ- rt Ω 3 Φ — - d μ- 3 n d Φ μ- • Φ cΩ 3" tr ιO rt co rt 3 a Φ ^ TJ ιΩ μ» μ- • tr 3

Claims: What is claimed is : 1. Isolated polynucleotide from coryneform bacteria, comprising a polynucleotide sequence which codes for the ppsA gene, chosen from the group consisting of a) polynucleotide which is identical to the extent of at least 70% to a polynucleotide which codes for a polypeptide which comprises the amino acid sequence of SEQ ID No. 2, b) polynucleotide which codes for a polypeptide which comprises an amino acid sequence which is identical to the extent of at least 70% to the amino acid sequence of SEQ ID No. 2, c) polynucleotide which is complementary to the polynucleotides of a) or b) , and d) polynucleotide comprising at least 15 successive nucleotides of the polynucleotide sequence of a) , b) or c) the polypeptide preferably having the activity of phosphoenol pyruvate synthase. 2. Polynucleotide according to claim 1, wherein the polynucleotide is a preferably recombinant DNA which is capable of replication in coryneform bacteria. 3. Polynucleotide according to claim 1, wherein the polynucleotide is an RNA. 4. Polynucleotide according to claim 2, comprising the nucleic acid sequence as shown in SEQ ID No. 1. 5. DNA according to claim 2 which is capable of replication, comprising (i) the nucleotide sequence shown in SEQ ID No. 1, or (ii) at least one sequence which corresponds to sequence (i) within the range of the degeneration of the genetic code, or (iii) at least one sequence which hybridizes with the sequence complementary to sequence (i) or (ii) , and optionally (iv) sense mutations of neutral function in (i) . 6. DNA according to claim 5 which is capable of replication, wherein the hybridization is carried out under a stringency corresponding to at most 2x SSC. 7. Polynucleotide sequence according to claim 1, which codes for a polypeptide which comprises the amino acid sequence shown in SEQ ID No. 2. 8. Coryneform bacteria in which the ppsA gene is enhanced, in particular over-expressed. 9. Process for the fermentative preparation of L-amino acids, in particular L-lysine, wherein the following steps are carried out: a) fermentation of the coryneform bacteria which produce the desired L-amino acid and in which at least the ppsA gene or nucleotide sequences which code for it are enhanced, in particular over- expressed; b) concentration of the L-amino acid in the medium or in the cells of the bacteria, and c) isolation of the L-amino acid. 10. Process according to claim 9, wherein bacteria in which further genes of the biosynthesis pathway of the desired L-amino acid are additionally enhanced are employed. 11. Process according to claim 9, wherein bacteria in which the metabolic pathways which reduce the formation of the desired L-amino acid are at least partly eliminated are employed. 12. Process according to claim 9, wherein a strain transformed with a plasmid vector is employed, and the plasmid vector carries the nucleotide sequence which codes for the ppsA gene. 13. Process according to claim 9, wherein the expression of the polynucleotide (s) which code(s) for the ppsA gene is enhanced, in particular over-expressed. 14. Process according to claim 9, wherein the catalytic properties of the polypeptide (enzyme protein) for which the polynucleotide ppsA codes are increased. 15. Process according to claim 9, wherein for the preparation of L-amino acids, coryneform microorganisms in which at the same time one or more of the genes chosen from the group consisting of 15.1 the dapA gene which codes for dihydrodipicolinate synthase, 15.2 the gap gene which codes for glyceraldehyde 3- phosphate dehydrogenase, 15.3 the tpi gene which codes for triose phosphate isomerase, 15.4 the pgk gene which codes for 3-phosphoglycerate kinase, 15.5 the zwf gene which codes for glucose 6- phosphate dehydrogenase, 15.6 the pyc gene which codes for pyruvate carboxylase, 15.7 the mqo gene which codes for malate-quinone oxidoreductase, 15.8 the lysC gene which codes for a feed-back resistant aspartate kinase, 15.9 the lysE gene which codes for lysine export, 15.10 the horn gene which codes for homoserine dehydrogenase 15.11 the ilvA gene which codes for threonine dehydratase or the ilvA(Fbr) allele which codes for a feed back resistant threonine dehydratase, 15.12 the ilvBN gene which codes for acetohydroxy- acid synthase, 15.13 the ilvD gene which codes for dihydroxy-acid dehydratase, 15.14 the zwal gene which codes for the Zwal protein, is or are enhanced or over-expressed are fermented. 16. Process according to claim 9, wherein for the preparation of L-amino acids, coryneform microorganisms in which at the same time one or more of the genes chosen from the group consisting of 16.1 the pck gene which codes for phosphoenol pyruvate carboxykinase, SEQUENCE LISTING <110> Degussa AG <120> Nucleotide sequences which code for the ppsA gene <130> 000175 BT <140> <141> <160> 2 <170> Patentln Ver. 2.1 <210> 1 <211> 1494 <212> DNA <213> Corynebacterium glutamicum <220> <221> CDS <222> (200) .. (1291) <223> ppsA gene <400> 1 cggcatccac tattgcctag gaaacatgct ggccaaactt caagccaaga tctgtctcga 60 ggaagtcacc aggcttgttc cttccctgca cttggttgcg gacaaagcta tcgggttccg 120 ggagaacctc tccttccgcg tccccacttc tgttcccgtg acttggaacg cttaacgctt 180 tattaaataa ggagacacc atg ace aac agt ttg aac ate ccg ttt gtc cag 232 Met Thr Asn Ser Leu Asn He Pro Phe Val Gin 1 5 10 cgc ttc gat gaa ggc ctg gat cct gtt eta gaa gta etc ggt ggc aag 280 Arg Phe Asp Glu Gly Leu Asp Pro Val Leu Glu Val Leu Gly Gly Lys 15 20 25 ggc get tea eta gtc ace atg aca gat get gga atg ccc gtt cca cct 328 Gly Ala Ser Leu Val Thr Met Thr Asp Ala Gly Met Pro Val Pro Pro 30 35 40 gga ttt gtg gtc act act gcc age ttt gat gaa ttc ate cgt gaa gca 376 Gly Phe Val Val Thr Thr Ala Ser Phe Asp Glu Phe He Arg Glu Ala 45 50 55 ggg gtt get gaa cac ate gat aaa ttc eta aac gat etc gat gca gaa 424 Gly Val Ala Glu His He Asp Lys Phe Leu Asn Asp Leu Asp Ala Glu 60 65 70 75 gat gtt aag gaa gtg gat cga gtt tct gcg ate ate cgc gat gag ctg 472 Asp Val Lys Glu Val Asp Arg Val Ser Ala He He Arg Asp Glu Leu 80 85 ' 90 tgc agt ctt gac gtt cca gag aat get cgt ttc gca gtg cac cag get 520 Cys Ser Leu Asp Val Pro Glu Asn Ala Arg Phe Ala Val His Gin Ala 95 100 105 tat cgc gat etc atg gaa cga tgc ggt ggc gac gtc ccg gtt get gtc 568 Tyr Arg Asp Leu Met Glu Arg Cys Gly Gly Asp Val Pro Val Ala Val 110 115 120 egg tea teg gcc act gee gaa gat ctg ccc gat get tec ttc gca ggg 616 Arg Ser Ser Ala Thr Ala Glu Asp Leu Pro Asp Ala Ser Phe Ala Gly 125 130 135 caa cag gac ace tat ctg tgg caa gtc ggt ttg age get gtc act gaa 664 Gin Gin Asp Thr Tyr Leu Trp Gin Val Gly Leu Ser Ala Val Thr Glu 140 145 150 155 cac ate cgt aaa tgc tgg get teg ctg ttc act tec cgt gcc att ate 712 His He Arg Lys Cys Trp Ala Ser Leu Phe Thr Ser Arg Ala He He 160 165 170 tac cgt ctg aaa aac aac ate ccc aat gag ggc etc tec atg gcg gta 760 Tyr Arg Leu Lys Asn Asn He Pro Asn Glu Gly Leu Ser Met Ala Val 175 180 185 gtt gtt caa aaa atg gtc aac tct cgt gtc gca ggc gtg gca ate act 808 Val Val Gin Lys Met Val Asn Ser Arg Val Ala Gly Val Ala He Thr 190 195 200 atg aat cct tec aac ggc gac cgc teg aag ate ace ate gat tec tea 856 Met Asn Pro Ser Asn Gly Asp Arg Ser Lys He Thr He Asp Ser Ser 205 210 215 tgg ggt gtt ggt gaa atg gtg gtc tea ggt gaa gtg aca cca gac aat 904 Trp Gly Val Gly Glu Met Val Val Ser Gly Glu Val Thr Pro Asp Asn 220 225 ' 230 235 ate ttg ctg gac aag ate acg ctg cag gtt gtc tec gaa cac att gga 952 He Leu Leu Asp Lys He Thr Leu Gin Val Val Ser Glu His He Gly 240 245 250 age aaa cac get gaa etc ate ccc gat gcc ace agt gga age etc gtg 1000 Ser Lys His Ala Glu Leu He Pro Asp Ala Thr Ser Gly Ser Leu Val 255 260 265 gaa aag ccc gtt gat gaa gaa cgc gca aac cgc cgc agt ctg act gat 1048 Glu Lys Pro Val Asp Glu Glu Arg Ala Asn Arg Arg Ser Leu Thr Asp 270 275 280 gag gaa atg etc get gtg gca caa atg get aag cgt gca gaa aaa cac 1096 Glu Glu Met Leu Ala Val Ala Gin Met Ala Lys Arg Ala Glu Lys His 285 290 295 tac aag tgc cca caa gat ate gaa tgg gcg ctg gac get gat ctg cca 1144 Tyr Lys Cys Pro Gin Asp He Glu Trp Ala Leu Asp Ala Asp Leu Pro 300 305 310 315 gat gga gaa aac ctt ctg tta ttg caa tec cgc ccg gaa act ate -cac 1192 Asp Gly Glu Asn Leu Leu Leu Leu Gin Ser Arg Pro Glu Thr He His 320 325 330 tec aac ggt gtg aag aag gaa ace cca act ccg cag get gcc aaa ace 1240 Ser Asn Gly Val Lys Lys Glu Thr Pro Thr Pro Gin Ala Ala Lys Thr 335 340 345 ata ggc ace ttc gat ttc age tea ate ace gtc gca atg ace ggc acg 1288 He Gly Thr Phe Asp Phe Ser Ser He Thr Val Ala Met Thr Gly Thr 350 355 360 aag taaaaccacc gcatcttttc gtcgaaaagc atctaaaagg agtttgacca 1341 Lys tggetaataa atetttccee aagccctecg atcttccagt gcccaagggc gctgaaggtt 1401 gggaagatct gtaccegtac tacctegttt teeaagaeaa gctcatggat eaagagaatg 1461 agaaattctg gttctgcgat tcacagcact ggc 1494 <210> 2 <211> 364 <212> PRT <213> Corynebacterium glutamicum <400> 2 Met Thr Asn Ser Leu Asn He Pro Phe Val Gin Arg Phe Asp Glu Gly 1 5 10 15 Leu Asp Pro Val Leu Glu Val Leu Gly Gly Lys Gly Ala Ser Leu Val 20 25 30 Thr Met Thr Asp Ala Gly Met Pro Val Pro Pro Gly Phe Val Val Thr 35 40 45 Thr Ala Ser Phe Asp Glu Phe He Arg Glu Ala Gly Val Ala Glu His 50 55 60 He Asp Lys Phe Leu Asn Asp Leu Asp Ala Glu Asp Val Lys Glu Val 65 70 75 80 Asp Arg Val Ser Ala He He Arg Asp Glu Leu Cys Ser Leu Asp Val 85 90 95 Pro Glu Asn Ala Arg Phe Ala Val His Gin Ala Tyr Arg Asp Leu Met 100 105 110 Glu Arg Cys Gly Gly Asp Val Pro Val Ala Val Arg Ser Ser Ala Thr 115 120 125 Ala Glu Asp Leu Pro Asp Ala Ser Phe Ala Gly Gin Gin Asp Thr Tyr 130 135 140 Leu Trp Gin Val Gly Leu Ser Ala Val Thr Glu His He Arg Lys Cys 145 150 155 160 Trp Ala Ser Leu Phe Thr Ser Arg Ala He He Tyr Arg Leu Lys Asn 165 170 175 Asn He Pro Asn Glu Gly Leu Ser Met Ala Val Val Val Gin Lys Met 180 185 190 Val Asn Ser Arg Val Ala Gly Val Ala He Thr Met Asn Pro Ser Asn 195 200 205 Gly Asp Arg Ser Lys He Thr He Asp Ser Ser Trp Gly Val Gly Glu 210 215 220 Met Val Val Ser Gly Glu Val Thr Pro Asp Asn He Leu Leu Asp Lys 225 230 235 240 He Thr Leu Gin Val Val Ser Glu His He Gly Ser Lys His Ala Glu 245 250 255 Leu He Pro Asp Ala Thr Ser Gly Ser Leu Val Glu Lys Pro Val Asp 260 265 270 Glu Glu Arg Ala Asn Arg Arg Ser Leu Thr Asp Glu Glu Met Leu Ala 275 280 285 Val Ala Gin Met Ala Lys Arg Ala Glu Lys His Tyr Lys Cys Pro Gin 290 295 300 Asp He Glu Trp Ala Leu Asp Ala Asp Leu Pro Asp Gly Glu Asn Leu 305 310 315 320 Leu Leu Leu Gin Ser Arg Pro Glu Thr He His Ser Asn Gly Val Lys 325 330 335 Lys Glu Thr Pro Thr Pro Gin Ala Ala Lys Thr He Gly Thr Phe Asp 340 345 350 Phe Ser Ser He Thr Val Ala Met Thr Gly Thr Lys 355 360

Inventors: BASTUCK CHRISTINE, BUCHHOLZ MICHAEL, MARX ACHIM, MOECKEL BETTINA, PFEFFERLE WALTER, BASTUCK, CHRISTINE, BUCHHOLZ, MICHAEL, MARX, ACHIM, MOECKEL, BETTINA, PFEFFERLE, WALTER
Applicants: DEGUSSA, DEGUSSA AG
Application year: 2001
Main classification: C12N15
IPC codes: C12N1, C12N9, C12N15, C12P13